Amazon on Tuesday debuted its latest healthcare offering—a prescription drug program that gives subscribers the ability to fill as many prescriptions as they need for a flat monthly fee, delivering an experience the company says is "fundamentally different" from other pharmacies. But Advisory Board's Gina Lohr and Chloe Bakst aren't so quick to label Amazon a disruptor in this space—here's why.
Writing for the Harvard Business Review, Lisa Zigarmi and Julie Diamond outline five steps leaders can take to effectively frame difficult conversations and help their teams address "undiscussables."
The healthcare sector saw a significant drop in employment at the start of the pandemic, but since then, the industry has largely rebounded to pre-pandemic levels. However, overall job growth remains below expectations, according to new research from the Peterson Center on Healthcare and the Kaiser Family Foundation. See the pandemic's impact on the healthcare industry on our interactive charts.
A lawsuit filed Wednesday by GenBioPro argues that West Virginia's statewide ban on the abortion pill mifepristone is unconstitutional because FDA has already approved the drug, marking one of a series of lawsuits throughout the United States over the legality of mifepristone.
For many patients with depression, it can take months of "trial-and-error" to find the antidepressant treatment that works for them. However, new research on biomarkers may be the key to getting patients the right antidepressant on the first try, Theresa Gaffney writes for STAT.
Prosecutors allege that former Theranos CEO Elizabeth Holmes attempted to "flee the country" following her January 2022 fraud conviction, in today's bite-sized hospital and health industry news from California and the District of Columbia.
Print All Daily Briefing Article from
01/25/2023
Share:
Have a Question?
x
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.
